A A A

Symposium “Integrating Research and Clinical Development in Ovarian Cancer“

Dozent: Diverse

Zielgruppen: alle Mitarbeiter * MPJ * Studenten

Punkte lt. Ärztekammer: 0
lt. Deutscher Pflegerat: 0

Anmeldung erforderlich: Ja
Online Anmeldung

Kosten: 0.00 Euro (0.00 Intern)

Termin: 17.05.2017 - 17.05.2017
Uhrzeit: 09:30 - 16:30
Raum: Center for Tumor Biology and Immunology - Hans-Meerwein-Straße 3 - Marburg

Symposium “Integrating Research and Clinical Development in Ovarian Cancer“

10:00 Emerging immune therapies in OC, Jalid Sehouli, Berlin
10:25 Anti-angiogenic therapy in OC, Domenica Lorusso, Milano
10:50 PARP inhibitors in OC therapy, Philipp Harter, Essen
11:15 Coffee break
11:30 Promotion of metastasis by p53 gain-offunction mutations, Thorsten Stiewe, Marburg
11:55 p53 as target and integration of translational research in international multicenter clinical trials,
           Nicole Concin, Leuven
12:20 Lunch
13:30 Towards a global picture of the OC microenvironment, Rolf Müller, Marburg
13:55 Chemokines and chemokine receptors in OC, Holger Bronger, Munich
14:20 Role of microRNAs and stromal heterogeneity in OC, Fatima Mechta-Grigoriou, Paris
14.45 Coffee break
15:00 Role of the cytotoxicity receptor NKG2D in cancer immunosurveillance,
            Elke Pogge von Strandmann, Marburg
15:25 Defective HLA antigen expression in OC and its potential clinical relevance, Soldano Ferrone, Boston
15:30 Immunotherapy in OC: first clinical data. Florian Heitz, Essen
15:55 Concluding remarks

Weitere Informationen


Persönliche Angaben


Thomas Bauer
Telefon: 06421-5864462
Philipps Universität
bauert@med.uni-marburg.de